How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry
By: The Congress of the United States, Congressional Budget Office ; [written by Anna Cook under the supervision of Jan Paul Acton and Elliot Schwartz].
Contributors: Acton, Jan Paul.; Schwartz, Elliot.; United States. Congressional Budget Office.
Series: A CBO study
Publisher: The Office
Published: 1998
Place of publication: [Washington, D.C.]
Language: eng
Number of pages: 75
Subjects: Drugs -- Prices -- United States.; Generic drugs -- Prices -- United States.; Pharmaceutical industry -- United States.; Competition -- United States.
Notes: Includes bibliographical references.